###begin article-title 0
###xml 38 60 38 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1, LOC387715/ARMS2</italic>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population
###end article-title 0
###begin p 1
The first two authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 85 104 85 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement factor H</italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH)</italic>
###xml 112 135 112 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HtrA serine peptidase 1</italic>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1),</italic>
###xml 149 189 149 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">age-related maculopathy susceptibility 2</italic>
###xml 191 207 191 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2)</italic>
To estimate the joint effects of single nucleotide polymorphysms (SNPs) in the genes complement factor H (CFH), HtrA serine peptidase 1 (HTRA1), and age-related maculopathy susceptibility 2 (LOC387715/ARMS2) in a Caucasian age related macular degeneration (AMD) case-control cohort.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 103 118 103 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 324 327 324 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 182 185 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
We genotyped three SNPs,  (exon 9, CFH),  (HTRA1 promoter, -512 bp), and  (6.6 kb upstream of HTRA1 in LOC387715/ARMS2) in 333 cases with advanced AMD (choroidal neovascularization [CNV] and geographic atrophy) and 171 age-matched examined controls. Association tests were performed for individual SNPs and jointly with the CFH SNP Y402H. Analyses for interaction were also performed.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 242 245 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 282 285 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;19</sup>
###xml 531 546 531 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 625 628 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
The linkage disequilibrium measure for two SNPs on 10q26,  and , is D'=0.8 and all four possible haplotypes of the two SNPs were detected in the samples. The allelic association test for  on the promoter of HTRA1 yielded p-values less than 10-10 for geographic atrophy, less than 10-16 for neovascularization, and less than 10-19 for the pooled phenotypes (with an odds ration [OR] of 3.973; 95% confidence interval [CI] 2.928, 5.390). Disease risk is conferred in a dosage-dependent fashion. Similar figures were observed for the LOC387715/ARMS2 SNP. No interaction was detected between either between the 10q26 SNPs or the CFH SNP.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 152 167 152 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH.</italic>
This is the first analysis to show that the two 10q26 SNPs are not in complete linkage disequilibrium. Our studies however show that both the HTRA1 and LOC387715/ARMS2 SNP appear to contribute equally to disease risk (both geographic atrophy and choroidal neovascularization) with no evidence of interaction with CFH.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 254 273 254 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">complement factor H</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH)</italic>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 487 527 487 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">age-related maculopathy susceptibility 2</italic>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 704 727 704 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HtrA serine peptidase 1</italic>
###xml 729 735 729 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1)</italic>
###xml 761 776 761 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 893 894 893 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
Several genes have now been associated with the development of age-related macular degeneration (AMD). The most consistently identified genetic variants lie within the regulators of complement activation (RCA) locus on chromosome 1, principally the gene complement factor H (CFH) [1-3], and the 10q26 chromosomal region [4-6]. Association analyses of this latter locus initially implicated the single nucleotide polymorphism (SNP) , located in the coding sequence of a gene now known as age-related maculopathy susceptibility 2 (ARMS2) [4-6], to be the variant most likely associated with AMD. Subsequent rigorous sequencing of the region revealed a polymorphism, , in the promoter of the adjacent gene, HtrA serine peptidase 1 (HTRA1), some 7 kb downstream of LOC387715/ARMS2, to be also associated with advanced AMD [7,8]. To date, this finding has been corroborated in two other Caucasian [9,10] one central European [11], and one Japanese [12] populations.
###end p 12
###begin p 13
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
Intriguingly, both  and  are in almost complete linkage disequilibrium in all cohorts examined thus far (D' >0.98) [7,12,13], limiting the ability of genetic association analyses to resolve the functional variant. Initial molecular biologic analyses suggest that the promoter SNP in HTRA1, a gene that encodes a heat shock serine protease found in retinal tissues, produces a change in the expression level of the gene [7,8]. Interestingly, HTRA1 expression has been reported to increase with age [14].
###end p 13
###begin p 14
###xml 15 30 15 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
Most recently, LOC387715/ARMS2 has been suggested to encode a mitochondrial-associated protein that is also found in the retina. The polymorphism which results in the substitution of serine-for-alanine at position 69 may result in misfolding of the protein [15].
###end p 14
###begin p 15
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 235 250 235 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
In this article, we present further analyses of the 10q26 polymorphisms in a Caucasian population from the USA with advanced AMD (both geographic atrophy and choroidal neovascularization) and assess joint effects of the HTRA1 SNP, the LOC387715/ARMS2 SNP  (A69S), and the CFH SNP  (Y402H).
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Phenotyping
###end title 17
###begin p 18
###xml 143 150 143 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 356 359 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
Sporadic advanced cases (average age 79 years of age, range 60 to 100 years of age) and controls (average age 74, range 63 to 92 years of age, Table 1) of Northern European Caucasian descent were ascertained from the clinical practices of P.F. and M.K. Diagnosis of AMD in was based upon the presence of geographic atrophy or choroidal neovascularization (CNV; equivalent to Age-Related Eye Disease Study [AREDS] category 4) [16]. Control subjects were at least 60 years of age, with no signs of AMD (defined as no drusen larger than 63 mum in diameter; equivalent to AREDS category 1).
###end p 18
###begin title 19
Summary of age distributions for the four phenotypic groups
###end title 19
###begin p 20
Counts, Hardy-Weinberg equilibrium tests, allele frequencies, genotypic association tests for three risk SNPs in each and combined cohorts.
###end p 20
###begin p 21
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
###xml 92 95 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 117 120 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 217 229 <span type="species:ncbi:9606">participants</span>
One hundred and eight patients with geographic atrophy (GA) together with 205 patients with CNV, 20 with both GA and CNV, and 171 age-matched examined controls were ascertained. Informed consent was obtained from all participants, and the procedures used conformed to the tenets of the Declaration of Helsinki.
###end p 21
###begin title 22
Genotyping
###end title 22
###begin p 23
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
Genotyping of , , and  was performed as described previously [17]. Specifically, PCR was performed using primers designed to amplify the genomic region containing each SNP ( forward: 5'-GGT GGT TCC TGT GTC CTT CA-3', reverse: 5'-GGG GTA AGG CCT GAT CAT CT-3';  forward: 5'-CGG ATG CAC CAA AGA TTC TCC-3', reverse: 5'-TTC GCG TCC TTC AAA CTA ATG G-3'). Following amplification, genotype determination was performed on the PCR products using either temperature gradient capillary electrophoresis (TGCE; REVEAL; SpectruMedix, State College, PA) or through direct sequencing using CEQ2000XL DNA analysis system (Beckman Coulter, Fullerton, CA).
###end p 23
###begin title 24
Statistical analyses
###end title 24
###begin p 25
###xml 36 37 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 173 174 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 196 203 192 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 291 292 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 435 437 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
Hardy-Weinberg Equilibrium (HWE) chi2 values in the entire sample and controls alone were calculated to identify possible genotyping errors. No extreme deviations (i.e., chi2 > 50) were observed (Table 2). Linkage disequilibrium (LD) was measured by the D' value. For each SNP, Pearson's chi2 tests with one degree of freedom for association were performed. Odds ratios (OR) and their respective confidence intervals were calculated, [18]. Both SNPHAP and PHASE were used to estimate the haplotype frequencies and to reconstruct the diplotype (haplotype pair) for each sample. Consistent results obtained by using both algorithms were taken for further regression analyses.
###end p 25
###begin title 26
Genotyping information and Fisher's exact tests for association between SNPs and disease status
###end title 26
###begin p 27
###xml 328 331 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 365 368 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 409 412 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
Genotyping data confirming Hardy-Weinberg equilibrium for all SNPs analyzed. Fisher's exact tests shows strong association between SNPs and advanced AMD disease status. Abbreviations: HWE=Hardy-Weinberg Equilibrium. Fisher's exact genotypic / allelic association test for various disease status: p-value. GA=geographic atrophy, CNV=choroidal neovascularization, GA+CNV refers to those individuals with GA and CNV in one or both eyes.
###end p 27
###begin p 28
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 402 403 402 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</sub>
###xml 436 437 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 444 445 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 446 447 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 465 466 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 473 474 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 475 476 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 483 484 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 485 486 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 602 603 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 610 611 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 612 613 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 620 621 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 622 623 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 630 631 603 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 632 633 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 635 636 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Joint ORs for two SNPs ( and complement factor H (CFH) Y402H, previously genotyped) were calculated using standard methods [19]. Marginal ORs and their confidence intervals for the two SNPs were calculated using logistic regression with SNPs CFH Y402H and  as independent variables [19]. The standard logistic regression models for marginal and joint effect (effect of marker Xi controlled for marker Xj) are formulated as logit(p)=beta0 + beta1X1 and logit(p)=beta0 + beta1X1 + beta2X2, respectively. For highly correlated SNPs ( and ), an interaction term was incorporated in the model: logit(p)=beta0 + beta1X1 + beta2X2 + beta3X1xX2.
###end p 28
###begin p 29
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
To assess the statistical significance of the effect, the likelihood ratio test is performed. To control for confounding, the Mantel-Hanzel (M-H) test for association with two variables was used [19]. Four genotypic models were considered (Full, Recessive, Multiplicative, and Dominant) and the conventional Aikake information criterion (AIC) [20] was used to assess the fit of each model.
###end p 29
###begin title 30
Results
###end title 30
###begin p 31
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 156 159 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;20</sup>
###xml 221 236 221 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 357 364 357 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
In our US Caucasian case-control cohort, the HTRA1 SNP showed strong disease association with both advanced forms of AMD, p<10-10 (geographic atrophy), p<10-16 (neovascularization), and p<10-20 for pooled phenotypes. The LOC387715/ARMS2 SNP showed similar levels of association. Strong association is also confirmed between disease status and the CFH SNP  (Table 2).
###end p 31
###begin p 32
###xml 164 171 164 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
The two 10q26 SNPs,  and , were also in strong linkage disequilibrium (D'=0.80), though not in complete LD as all possible diplotypes were found in the population. Table 3 shows how the four potential haplotypes produced by the two SNPs were distributed; AMD cases were approximately three times more likely to have the high risk haplotype  'T' +  'A' than controls.
###end p 32
###begin title 33
Haplotype frequencies with estimated standard deviations in parentheses
###end title 33
###begin p 34
###xml 30 39 30 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
Haplotype frequencies for the LOC387715 and HTRA1 SNPs (with estimated standard deviations in parentheses) showing the presence of all four potential haplotypes in the cohort. P-value for independence between haplotypes and disease: 1.1e-22.
###end p 34
###begin p 35
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 237 252 237 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 266 273 266 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 526 533 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
Table 4 shows joint and marginal odds ratios for the HTRA1 and CFH SNPs. Odds ratios of having the disease rise to almost 200 in individuals who are homozygous for the risk alleles in both genes. Similar odds ratios are observed for the LOC387715/ARMS2 and CFH SNP (Table 5). When joint odds ratios were computed for the two highly correlated SNPs on 10q26 and the interaction terms considered in the regression model, the resulting confidence interval encompasses 0 and infinity due to insufficient sample size in each cell (Table 6).
###end p 35
###begin title 36
Joint and marginal odds ratios (pooled cases) for  and 
###end title 36
###begin p 37
Marginal odds ratios are calculated based on a logistic regression model by assuming an additive effect of two SNPs after a logit transformation on odds ratio
###end p 37
###begin title 38
Joint and marginal odds ratios (pooled cases) for  and 
###end title 38
###begin p 39
Marginal odds ratios are calculated based on a logistic regression model by assuming an additive effect of two SNPs after a logit transformation on odds ratio.
###end p 39
###begin title 40
Joint genotype counts in cases/controls for  and 
###end title 40
###begin p 41
Joint genotype counts of controls/cases, sample size too small to fit regression model with interaction terms.
###end p 41
###begin p 42
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t7">Table 7</xref>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 226 233 226 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t8">Table 8</xref>
###xml 396 403 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
###xml 547 555 547 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t10">Table 10</xref>
Haplotype analyses of these two closely located SNPs were therefore employed using SNPHAP and PHASE programs (Table 7). Under the regression framework, no interaction was detected between the 10q26 haplotypes and the CFH SNP (Table 8). After dropping the interaction term the effect of one controlled for the other can be estimated and tested for significance based on the likelihood ratio test (Table 9). Estimated haplotype frequencies, diplotype counts, odds ratio, and p-values for testing independ for all observed diplotypes are provided in Table 10.
###end p 42
###begin title 43
Tests for model fit of the effects in  and 
###end title 43
###begin p 44
Models for  x . Note: According to AIC value, Mul x Mul model fits the data best. Similar results for  x .
###end p 44
###begin title 45
Joint analyses of the CFH SNP and 10q26 haplotypes
###end title 45
###begin p 46
###xml 243 250 243 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
The haplotype information for 10q26 gene is estimated using software PHASE. By treating the haplotype GG (formed by high risk alleles G and G at  and ) as a new "allele", we studied the joint and main effects of CFH SNP-10q26 haplotypes as in Table 3. Here a recessive mode of inheritance for 10q26 gene is assumed so that the gentotypes are classified to GG/GG and non GG/GG.
###end p 46
###begin title 47
Estimated frequencies and their standard deviations of haplotypes for  and 
###end title 47
###begin p 48
Presented in parentheses are estimated standard deviations. All the results were obtained by software SNPHAP using joint genotypes of SNPs  and .
###end p 48
###begin title 49
Counts, odds ratio, and p-value for testing independence for all observed diplotypes ( x )
###end title 49
###begin p 50
Odds ratios and their CIs are based on logistic regression models. Where counts are less than 6, ORs are ignored; p-values are for Fisher's exact tests. The phase-known diplotypes and estimated diplotypes were pooled, which were sufficient for haplotype analyses. P-value for testing independence of disease and all diplotypes is 4.76e-24.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 131 146 131 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 764 767 764 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 936 939 936 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 83 86 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
Our data confirm the association between advanced AMD (both geographic atrophy and CNV) and the 10q26 SNPs  (HTRA1 promoter) and  (LOC387715/ARMS2 A69S), independent of the CFH Y402H polymorphism. In all previous papers which examined linkage disequilibrium in the 10q26 region, these two SNPs have been reported to be in almost complete linkage disequilibrium [7,13]. This was not the case in our population where the D' between the SNPs was 0.80. This is a critical finding as it does indicate that other studies using larger populations may be able to determine which of the two 10q26 SNPs may be contributing most to disease status. The number of individuals in our study was too small to permit this. Odds ratios of having advanced AMD, when adjusted for the CFH SNP, were not significantly different for either of the 10q26 SNPs genotyped in our cohort. Each of the two SNPs also confers similar odd ratios when combined with the CFH SNP. Neither SNP was more clearly associated with disease status nor with advanced AMD phenotype though arguably if our cohort is enlarged substantially it might be possible to distinguish which SNP contribute the most risk.
###end p 52
###begin p 53
###xml 18 20 18 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
Previous studies [21] have not identified gene-locus interaction between CFH and the region on chromosome 10q26. Our analyses are in agreement with this. Thus it seems likely that CFH and 10q26 contribute independently to AMD development, at least at the genomic level.
###end p 53
###begin p 54
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 145 160 145 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 328 343 328 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1,</italic>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH,</italic>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 578 581 578 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
There remains an enormous amount to be learned about the genetic etiology of AMD. Nonetheless, there is little question that either HTRA1 and/or LOC387715/ARMS2 or a 10q26 haplotype that expands more than two SNPs play a crucial role in determining the advanced AMD phenotypes. Functional consequences from the polymorphisms of LOC387715/ARMS2 or HTRA1, or even CFH, have yet to be determined. Our current data indicate that in a Caucasian population from the USA, the HTRA1 promoter SNP is strongly associated with advanced AMD but appears to exert its effect independently of CFH.
###end p 54
###begin title 55
Acknowledgements:
###end title 55
###begin p 56
This work is supported by grants from the National Institutes of Health (NIH) National Eye Institute R01-EY12203 (Dr. Klein) R01-EY015771 and R21-EY018127 (J.H.); the Foundation Fighting Blindness, Owing Mills, MD (P.J.F.); the Macular Degeneration Center Research Fund, Casey Eye Institute, Oregon Health & Science University, Portland (M.L.K., P.J.F.), and Research to Prevent Blindness, New York, NY (unrestricted grant to Casey Eye Institute, Career Development Award to PJF). Verto Institute, LLC; Macular Vision Research Foundation; Ellison Foundation for Medical Research American Health Assistance Foundation (J.H.).
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 58
###begin article-title 59
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 59
###begin article-title 60
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 60
###begin article-title 61
Susceptibility genes for age-related maculopathy on chromosome 10q26.
###end article-title 61
###begin article-title 62
Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.
###end article-title 62
###begin article-title 63
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
###end article-title 63
###begin article-title 64
HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration.
###end article-title 64
###begin article-title 65
Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration.
###end article-title 65
###begin article-title 66
Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population.
###end article-title 66
###begin article-title 67
HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.
###end article-title 67
###begin article-title 68
Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population.
###end article-title 68
###begin article-title 69
###xml 12 17 <span type="species:ncbi:9606">human</span>
The role of human HtrA1 in arthritic disease.
###end article-title 69
###begin article-title 70
A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.
###end article-title 70
###begin article-title 71
design implications. AREDS report no. 1.
###end article-title 71
###begin article-title 72
Complement factor H polymorphisms in Japanese population with age-related macular degeneration.
###end article-title 72
###begin article-title 73
The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration.
###end article-title 73

